Vaccines

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

Understanding the role of microbial fermentation in the production of mRNA vaccines.

When it comes to influenza, chicken egg-based vaccines have achieved much, but emerging approaches are ready to fly the coop.

What lies ahead for antibody discovery? We ask experts from RQ Bio.

Discussing the challenges associated with flu vaccine development – and the emerging technologies hoping to tackle them.

Why is self-amplifying mRNA gaining more and more attention in the vaccine space?